The Effect of Royal Jelly on the recovery of Hepatitis B patients

Study of the Effect of Royal Jelly on the Healing Process of Patients Infected with Hepatitis B Virus and the Expression of Toll-like Receptors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210329050786N1

Enrollment

Registered

2021-05-09

Start date

2021-05-22

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B. Acute hepatitis B

Interventions

In this study, 50 Hepatitis B virus infected patients will be treated with oral administration of royal jelly at a rate of one gram per day for a month. Royal jelly will be used as an intervention age

Eligibility

Sex/Gender

All

Age

20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Infected with Hepatitis B for more than six months

Exclusion criteria

Exclusion criteria: Infected by other viruses Suffering from immune related diseases Receiving drugs that affect the immune system

Design outcomes

Primary

Measure	Time frame
Gene expression of Toll-like receptors will be measured in the Hepatitis B infected patients before and after oral administration of Royal Jelly. Timepoint: Before and after taking Royal Jelly orally. Method of measurement: Real time PCR assay.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Naghib

Islamic Azad University

mnaghib1359@gmail.com+98 34 3244 2523

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026